Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,475 | -1,079 | -3,044 | -4,038 | -6,997 |
| Depreciation Amortization | 555 | 668 | 941 | 1,003 | 1,545 |
| Accounts receivable | 61 | -422 | 370 | 476 | 1,067 |
| Accounts payable and accrued liabilities | -4 | 277 | -379 | 473 | -669 |
| Other Working Capital | -137 | -60 | 338 | -6 | -1,015 |
| Other Operating Activity | 402 | 733 | 1,964 | 608 | 2,691 |
| Operating Cash Flow | $-597 | $116 | $190 | $-1,484 | $-3,378 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 667 | 1,009 | -175 |
| PPE Investments | -19 | -18 | -47 | -108 | 953 |
| Other Investing Activity | -196 | -147 | -183 | -271 | -197 |
| Investing Cash Flow | $-215 | $-165 | $437 | $630 | $581 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -53 | -593 | 2,434 |
| Debt Issued | N/A | N/A | N/A | 1,715 | 500 |
| Debt Repayment | -5 | -16 | -967 | -547 | -2,055 |
| Common Stock Issued | N/A | 19 | 22 | 52 | 86 |
| Other Financing Activity | -150 | -160 | 0 | -28 | 2,764 |
| Financing Cash Flow | $-155 | $-157 | $-998 | $599 | $3,729 |
| Beginning Cash Position | 1,146 | 1,352 | 1,723 | 1,978 | 1,045 |
| End Cash Position | 180 | 1,146 | 1,352 | 1,723 | 1,978 |
| Net Cash Flow | $-966 | $-206 | $-371 | $-255 | $932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -597 | 116 | 190 | -1,484 | -3,378 |
| Capital Expenditure | -19 | -18 | -47 | -108 | -110 |
| Free Cash Flow | -616 | 98 | 143 | -1,592 | -3,487 |